CN115698054A - 包含肽的组合物及其用途 - Google Patents

包含肽的组合物及其用途 Download PDF

Info

Publication number
CN115698054A
CN115698054A CN202180036243.9A CN202180036243A CN115698054A CN 115698054 A CN115698054 A CN 115698054A CN 202180036243 A CN202180036243 A CN 202180036243A CN 115698054 A CN115698054 A CN 115698054A
Authority
CN
China
Prior art keywords
gly
pro
hyp
cys
composition according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202180036243.9A
Other languages
English (en)
Chinese (zh)
Inventor
小嶋健太郎
田中寛
新开阳一郎
小出隆规
市瀬慎一郎
能势博
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cora Genetics
Original Assignee
Cora Genetics
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cora Genetics filed Critical Cora Genetics
Publication of CN115698054A publication Critical patent/CN115698054A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
    • A61L27/227—Other specific proteins or polypeptides not covered by A61L27/222, A61L27/225 or A61L27/24
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/52—Hydrogels or hydrocolloids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/16—Materials or treatment for tissue regeneration for reconstruction of eye parts, e.g. intraocular lens, cornea

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Toxicology (AREA)
  • Dermatology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dispersion Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CN202180036243.9A 2020-09-02 2021-08-27 包含肽的组合物及其用途 Pending CN115698054A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2020147265 2020-09-02
JP2020-147265 2020-09-02
PCT/JP2021/031436 WO2022050176A1 (ja) 2020-09-02 2021-08-27 ペプチドを含む組成物及びその用途

Publications (1)

Publication Number Publication Date
CN115698054A true CN115698054A (zh) 2023-02-03

Family

ID=80491732

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202180036243.9A Pending CN115698054A (zh) 2020-09-02 2021-08-27 包含肽的组合物及其用途

Country Status (5)

Country Link
US (1) US20230295269A1 (https=)
EP (1) EP4209505A4 (https=)
JP (1) JP7774276B2 (https=)
CN (1) CN115698054A (https=)
WO (1) WO2022050176A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023127888A1 (en) * 2021-12-29 2023-07-06 Kola-Gen Pharma Inc. Novel peptides

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5601437B2 (ja) * 2004-02-16 2014-10-08 株式会社テクノネットワーク四国 コラーゲン様構造を有するポリペプチド
US9579273B2 (en) * 2011-12-14 2017-02-28 The Kitasato Institute Delivery of therapeutic agents by a collagen binding protein
WO2016208673A1 (ja) 2015-06-25 2016-12-29 学校法人早稲田大学 コラーゲン様構造を有する重合ペプチド及びゲル
JP2017014126A (ja) * 2015-06-29 2017-01-19 学校法人早稲田大学 抗微生物活性を有するコラーゲン様ペプチド及びその組成物

Also Published As

Publication number Publication date
JP7774276B2 (ja) 2025-11-21
JPWO2022050176A1 (https=) 2022-03-10
EP4209505A4 (en) 2024-10-23
EP4209505A1 (en) 2023-07-12
US20230295269A1 (en) 2023-09-21
WO2022050176A1 (ja) 2022-03-10

Similar Documents

Publication Publication Date Title
ES2594281T3 (es) Inhibidores polipeptídicos de HSP27 quinasa y usos de los mismos
JP4310588B2 (ja) 新規ペプチドおよびその医薬用途
CN102791283A (zh) 转化生长因子-β1(TGF-β1)抑制剂肽治疗角膜纤维化和/或角膜浑浊的应用
ES2366333T3 (es) Proteína quimérica.
JP2024531731A (ja) 生体模倣角膜及びその製造方法
EA029070B1 (ru) Способ задержки развития катаракты и пресбиопии
JP7774276B2 (ja) ペプチドを含む組成物及びその用途
US20240016900A1 (en) Collagen peptide-based medicament compositions and uses thereof
JP7787610B2 (ja) ポリエチレングリコール化コラーゲン様タンパク質の製造方法及びその使用
CN117157308A (zh) 细胞穿膜肽变体及其用途
US11998589B2 (en) PEGylated peptide amphiphile nanofibers and methods of use
JP4253743B2 (ja) 新規ペプチドおよびその医薬用途
CN106220714B (zh) 一种抑制新生血管的多肽、含有该多肽的药物及其应用
AU2017206626A1 (en) Pharmaceutical formulations and their use for the treatment of retinitis pigmentosa
CN101503458B (zh) 预防和治疗血管新生的小分子多肽及其应用
JP6693728B2 (ja) 新規な機能性ペプチド
WO2012000409A1 (zh) 具有抑制新生血管活性的肽及其应用
JPH0680694A (ja) 創傷治癒に活性のあるポリペプチド・ポリマーイオン複合体
CN119606865A (zh) 基于Tβ4与EISA水凝胶治疗角膜瘢痕的载药体系
ES2705602T3 (es) Composiciones de péptidos anfifílicos purificadas y usos de las mismas
HK40118464A (zh) 基於胶原蛋白肽的药物组合物及其用途
CN104004057A (zh) 一类新的抑制新生血管的小肽及其应用
CA2255477A1 (en) Human vitreous and pharmaceutical compositions

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination